Trial intelligence / Profile preview

Belatacept-based Regimen in Renal Transplant

NCT00565773Phase 2Completed

Start
Dec 2007
Primary completion
Jul 2017
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of belatacept in kidney transplant rejection. Started Dec 2007; status: completed.

02

Drugs

belatacept
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00565773.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00565773.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call